Highly active antiretroviral therapy versus zidovudine for prevention of mother-to-child transmission in a programmatic setting, Botswana.
about
Antiretroviral drug regimens to prevent mother-to-child transmission of HIV: a review of scientific, program, and policy advances for sub-Saharan AfricaMaternal antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Malawi: maternal and infant outcomes two years after deliveryEffectiveness of a prevention of mother-to-child HIV transmission programme in an urban hospital in AngolaMother to Mother (M2M) peer support for women in Prevention of Mother to Child Transmission (PMTCT) programmes: a qualitative study.Cotrimoxazole prophylaxis and risk of severe anemia or severe neutropenia in HAART-exposed, HIV-uninfected infants.Initial programmatic implementation of WHO option B in Botswana associated with increased projected MTCTProgress in the prevention of mother to child transmission of HIV in three regions of Tanzania: a retrospective analysis.Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV.Tracking the progress of HIV: the impact of point-of-care tests on antiretroviral therapyA post-partum single-dose TDF/FTC tail does not prevent the selection of NNRTI resistance in women receiving pre-partum ZDV and intrapartum single-dose nevirapine to prevent mother-to- child HIV-1 transmission.HIV in Africa: Challenges and Directions for the Next Decade.[Use of dried blood spots in early diagnosis of HIV-1 infection in children born to HIV-infected mothers as part of the prevention of mother-to-child transmission in Benin].
P2860
Q27014960-8D1CDB35-6062-4D09-875A-138BD666A3B9Q28534751-43586DBD-82AA-4D02-A8C7-48B17F44CA6DQ34257477-4D85DDC9-0A89-411C-A7A9-BC7EDE9426F1Q34765819-3F7DE0B8-355E-4F4A-AF2A-BAB19C38DA79Q35004909-46558ED3-E0A6-495E-B206-E180509F3237Q35079468-780297E9-35FD-4BD7-9AC9-61ADC86C4426Q35097481-C602407D-5D64-4437-B8A1-4707B55618F3Q35625548-B0DD22F3-9287-4D13-9A12-34DABB4CA28AQ37225313-02E27B2B-5947-4B95-91DD-EC45C3C0F310Q37320315-64DA4F04-D659-4E7E-BA95-B2D9360EF49CQ38419599-F24F4349-96E5-4B21-9ADD-40290CEAC5F8Q40623087-BE062149-299D-4E08-9E64-444AB32E3C58
P2860
Highly active antiretroviral therapy versus zidovudine for prevention of mother-to-child transmission in a programmatic setting, Botswana.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Highly active antiretroviral t ...... rogrammatic setting, Botswana.
@ast
Highly active antiretroviral t ...... rogrammatic setting, Botswana.
@en
type
label
Highly active antiretroviral t ...... rogrammatic setting, Botswana.
@ast
Highly active antiretroviral t ...... rogrammatic setting, Botswana.
@en
prefLabel
Highly active antiretroviral t ...... rogrammatic setting, Botswana.
@ast
Highly active antiretroviral t ...... rogrammatic setting, Botswana.
@en
P2093
P2860
P50
P1476
Highly active antiretroviral t ...... rogrammatic setting, Botswana.
@en
P2093
Aida Asmelash
Haruna Jibril
Josephine Tlale
Koona Keapoletswe
Michael D Hughes
Oluwemimo Jayeoba
Roger L Shapiro
Scott Dryden-Peterson
Taolo A Modise
P2860
P304
P356
10.1097/QAI.0B013E31822D4063
P407
P577
2011-11-01T00:00:00Z